How is artificial intelligence (AI) being applied to rare neuromuscular disorders today?
This upcoming DREAMS webinar will explore concrete applications of AI, machine learning and real-world data across rare neuromuscular diseases, bringing together organisations actively developing and applying these approaches.
The session will cover several key areas, including earlier identification and diagnosis, machine learning for target and drug discovery, and the use of population-scale real-world data to address diagnostic gaps and identify patients who may be eligible for existing therapies.
Speakers will share their current approaches, the challenges they are addressing and their perspectives on the practical role of AI in rare neuromuscular disorders.
The webinar is organised by DREAMS (Drug REpurposing with Artificial intelligence for Muscular disorderS), a Horizon Europe research project combining iPSC-based disease models, phenotypic drug screening and AI to investigate shared biological mechanisms, therapeutic targets and potential drug candidates across rare neuromuscular disorders.
Moderator
- François Lamy | AFM-Téléthon
Speakers
- Gohun Seo | 3billion
- Rubal Ravinder | KANTIFY
- Christopher Rudolf | Volv Global
The presentations will be followed by a live Q&A session with the speakers.
Date: 15 October 2026
Format: Online via Microsoft Teams